In prostate cancer, Jag1-ICD has been shown to upregulate the expression of androgen receptor variants (AR-Vs) and to enhance AR transactivation under both androgen-dependent and -independent conditions [180]. The gene discussed is JAG1; the disease is Familial prostate cancer.